Target amount for reasonable incomplete revascularization

Original title: Reasonable incomplete revascularisation after percutaneouscoronary intervention: the SYNTAX Revascularisation Index. Reference: Philippe Généreux et al. EuroIntervention 2014;10-online publish-ahead-of-print.

While the absolute amount of residual disease after coronary angioplasty is associated with poor prognosis, the proportion of treated coronary disease modifying the prognosis is still to be determined. This study attempted to quantify the proportion of coronary disease treated by angioplasty and assessed their impact on the results using a new instrument, the rate of revascularization SYNTAX. Residual baseline SYNTAX score was calculated in 2618 patients registered in the ACUITU study. SYNTAX revascularization index is calculated using the following formula: SYNTAX revascularization index = (1-[residual SYNTAX / basal SYNTAX]) × 100. Results were examined according to 3 groups of revascularization rate SYNTAX: 100% (complete revascularization), 50-99% and <50%. SYNTAX average revascularization rate was 85%, with 1079 patients (41.2%) at 100% rate, 907 patients (34.6%) between 50 and 99% rate and 632 patients (24.1%) at <50% rate. 

At one year, adverse events (including death) were inversely proportional to SINTAX revascularization SYNTAX. In the ROC curves, the cutoff rate of SYNTAX revascularization forecast with the best accuracy for predicting death was <80% (area under the curve of 0.60, IC 95% 0.53 to 0.67, p <0.0001). In the multivariate analysis, the new index was an independent predictor of mortality at one year ([HR] 2.17, IC 95%: 1.05-4.35, p = 0.03) and when compared with other scores it was superior in the ability to predict one-year mortality. 

Conclusion 

SYNTAX revascularization index is a new method to quantify the proportion of coronary heart disease treated with angioplasty. Since their correlation with mortality, the new tool could be useful for measuring the degree of revascularization, being ≥80% index a reasonable target. 

Editorial comment 

The baseline, residual, and SYNTAX index have different meanings and play different roles in daily clinical practice. Baseline score can be used to predict the outcome before revascularization and help decide between angioplasty or surgery, while the residual SYNTAX and SYNTAX index give us prognostic information after the procedure but also assist as a guide about the amount of revascularization or in other words, how much incomplete revascularization we can tolerate. 

All this needs to be validated in other studies that include more patients with multivessel since the average basal SYNTAX of ACUITY study was only 9. Calculating a score prior to the procedure and then again calculating the score and integrate those results in a formula, may be useful in a particular patient, but very challenging in daily practice

SOLACI

More articles by this author

Polymer-Free vs. Biodegradable Polymer Stents: SORT OUT IX 5-Year Outcomes

In a constant strive to achieve life time management, interventional cardiologists focus on optimizing coronary scaffolds, which calls for the development of devices with...

Chronic Stent Recoil and Its Long-Term Effects

The evolution of stent technology—including new scaffold designs, thinner struts, and more biocompatible polymers—has brought about an emerging concern: the late loss of structural...

PROSPECT II Substudy: Relationship Between Different Levels of hs-CRP and Vulnerable Plaque Characteristics in Patients with NSTEMI

Inflammation plays a key role in the onset and progression of atherosclerosis and has been linked to a higher risk of cardiovascular events, regardless...

Aspirin vs. Clopidogrel Monotherapy After 1 Month of ACS: Subgroup Analysis Based on Bleeding Risk and MI Type

Current guidelines still recommend dual antiplatelet therapy (DAPT) for 12 months following percutaneous coronary intervention (PCI) as the standard treatment in patients with acute...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Heterotopic Treatment of the Tricuspid Valve

Tricuspid regurgitation (TR) has been associated to high morbimortality, mainly due to the development of cardiac failure, peripheral edema, ascites, kidney failure and cardiohepatic...

Polymer-Free vs. Biodegradable Polymer Stents: SORT OUT IX 5-Year Outcomes

In a constant strive to achieve life time management, interventional cardiologists focus on optimizing coronary scaffolds, which calls for the development of devices with...

Three-Year Outcomes of Mitral Valve-in-Valve Therapy with Balloon-Expandable Valves in the United States

Courtesy of Dr. Juan Manuel Pérez. Mitral Valve-in-Valve (MViV) implantation with balloon-expandable valves has become a solid alternative for patients with degenerated mitral bioprostheses. However,...